These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10991954)
1. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. Mulato AS; Ho ES; Cihlar T J Pharmacol Exp Ther; 2000 Oct; 295(1):10-5. PubMed ID: 10991954 [TBL] [Abstract][Full Text] [Related]
2. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Cihlar T; Ho ES; Lin DC; Mulato AS Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):641-8. PubMed ID: 11563082 [TBL] [Abstract][Full Text] [Related]
3. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Cihlar T; Lin DC; Pritchard JB; Fuller MD; Mendel DB; Sweet DH Mol Pharmacol; 1999 Sep; 56(3):570-80. PubMed ID: 10462545 [TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs]. Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588 [TBL] [Abstract][Full Text] [Related]
5. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates. Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525 [TBL] [Abstract][Full Text] [Related]
6. Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3. Honjo H; Uwai Y; Aoki Y; Iwamoto K Biopharm Drug Dispos; 2011 Dec; 32(9):518-24. PubMed ID: 22072415 [TBL] [Abstract][Full Text] [Related]
7. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. Takeda M; Khamdang S; Narikawa S; Kimura H; Hosoyamada M; Cha SH; Sekine T; Endou H J Pharmacol Exp Ther; 2002 Aug; 302(2):666-71. PubMed ID: 12130730 [TBL] [Abstract][Full Text] [Related]
8. Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1. Masuda S; Saito H; Inui KI J Pharmacol Exp Ther; 1997 Dec; 283(3):1039-42. PubMed ID: 9399974 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. Ho ES; Lin DC; Mendel DB; Cihlar T J Am Soc Nephrol; 2000 Mar; 11(3):383-393. PubMed ID: 10703662 [TBL] [Abstract][Full Text] [Related]
10. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans. Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir. Fu XZ; Ou Y; Pei JY; Liu Y; Li J; Zhou W; Lan YY; Wang AM; Wang YL Eur J Med Chem; 2012 Mar; 49():211-8. PubMed ID: 22305613 [TBL] [Abstract][Full Text] [Related]
13. [Tubular transporters OAT1 and MRP2 and clearance of adefovir]. Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698 [TBL] [Abstract][Full Text] [Related]
14. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). Bleasby K; Hall LA; Perry JL; Mohrenweiser HW; Pritchard JB J Pharmacol Exp Ther; 2005 Aug; 314(2):923-31. PubMed ID: 15914676 [TBL] [Abstract][Full Text] [Related]
15. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849 [TBL] [Abstract][Full Text] [Related]
16. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. Khamdang S; Takeda M; Noshiro R; Narikawa S; Enomoto A; Anzai N; Piyachaturawat P; Endou H J Pharmacol Exp Ther; 2002 Nov; 303(2):534-9. PubMed ID: 12388633 [TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier. Nozaki Y; Kusuhara H; Endou H; Sugiyama Y J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319 [TBL] [Abstract][Full Text] [Related]
18. Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation. Cihlar T; Laflamme G; Fisher R; Carey AC; Vela JE; Mackman R; Ray AS Antimicrob Agents Chemother; 2009 Jan; 53(1):150-6. PubMed ID: 19001108 [TBL] [Abstract][Full Text] [Related]
19. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Apiwattanakul N; Sekine T; Chairoungdua A; Kanai Y; Nakajima N; Sophasan S; Endou H Mol Pharmacol; 1999 May; 55(5):847-54. PubMed ID: 10220563 [TBL] [Abstract][Full Text] [Related]
20. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. Takeda M; Khamdang S; Narikawa S; Kimura H; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Endou H J Pharmacol Exp Ther; 2002 Mar; 300(3):918-24. PubMed ID: 11861798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]